Virus therapy takes on childhood brain tumors: a new hope for recurrent cases?

NCT ID NCT06914479

First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 30 times

Summary

This early-stage trial tests a new treatment for children and young adults (ages 3-39) with recurrent malignant brain tumors that can be surgically removed. The therapy uses two lab-modified viruses (AdV-HSV1-TK and AdV-Flt3L) injected into the tumor to kill cancer cells and boost the immune system, along with an oral herpes medication (valacyclovir) to make the process work. The main goal is to find the safest dose and check for side effects, with only 11 participants enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT MALIGNANT BRAIN NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Michigan Comprehensive Cancer Center

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.